ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

April 18, 1986

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

Also: CALGB elects Schilsky to third term as chairman.

July 16, 2004

Study Finds Nearly Two-Thirds Of Children Return to Hospital Following Stem Cell Transplant

April 26, 2013

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.

November 9, 2001